Ask anyone living with arthritis how their diagnosis happened, and you’ll often hear the same story: a swollen joint here, an ache that wouldn’t go away there, months of wondering what it meant. By the time many people finally get an answer, inflammation has already left its mark—stiffness that won’t fully resolve, joints that never quite work the way they used to.
It’s a frustrating pattern, but it’s also a question scientists are determined to answer: what if arthritis could be caught before any of that damage happens?
That question sits at the heart of research supported by the Arthritis National Research Foundation (ANRF). Rather than waiting for arthritis to announce itself through pain and swelling, ANRF-funded scientists are searching for its earliest, quietest signals—the subtle changes that show up long before a diagnosis would typically be made. The goal is a fundamental shift in arthritis care: from repairing damage after the fact, to stopping it before it starts.
For children, this work carries particular urgency. Juvenile psoriatic arthritis can be hard to spot, and some children already have joint damage before doctors identify what’s wrong. At Children’s Hospital of Philadelphia, Dr. Anna Costello is using ANRF funding to explore whether musculoskeletal ultrasound—an imaging technique that can reveal inflammation forming around joints and tendons—might give physicians a way to see trouble coming. If her research succeeds, doctors could recognize the disease sooner and start protecting a child’s mobility years earlier than they can today.
Photo disclaimer: The image shown is for illustrative purposes only and does not depict Dr. Anna Costello or the actual research described.
Meanwhile, at Washington University in St. Louis, Dr. Nicholas Borcherding is looking somewhere less visible: the immune system. He describes it as a kind of living record, holding traces of what the body has already fought, what it’s dealing with now, and what may be coming. Using computer programs he’s built himself, Dr. Borcherding sifts through immense amounts of immune cell data, searching for patterns that might flag psoriatic arthritis and uveitis before symptoms fully emerge. His hope is that this approach could eventually help doctors not just detect disease earlier, but predict how a given patient will respond to treatment—turning guesswork into strategy.
Different diseases, different tools, same underlying hope: a future where answers come sooner, treatment starts sooner, and patients keep more of the mobility and health they’d otherwise lose to delay.
Discoveries like these don’t happen by accident. They start with a question, and they require someone willing to fund the pursuit of an answer. That’s the role ANRF donors play—giving early-career researchers the support they need to chase down the earliest clues of arthritis, before the disease has the chance to cause harm that can’t be undone.
